Cambridge Investment Research Advisors’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.82M Buy
21,154
+4,029
+24% +$347K 0.01% 1497
2025
Q1
$1.56M Sell
17,125
-3,999
-19% -$365K 0.01% 1512
2024
Q4
$1.82M Sell
21,124
-41,912
-66% -$3.6M 0.01% 1426
2024
Q3
$6.19M Buy
63,036
+37,499
+147% +$3.68M 0.02% 701
2024
Q2
$2.37M Sell
25,537
-212
-0.8% -$19.7K 0.01% 1176
2024
Q1
$2.4M Buy
25,749
+699
+3% +$65.1K 0.01% 1154
2023
Q4
$2.17M Sell
25,050
-725
-3% -$62.9K 0.01% 1147
2023
Q3
$2.12M Sell
25,775
-163
-0.6% -$13.4K 0.01% 1099
2023
Q2
$2.21M Buy
25,938
+3,592
+16% +$305K 0.01% 1113
2023
Q1
$1.86M Buy
22,346
+8,389
+60% +$699K 0.01% 1167
2022
Q4
$1.19M Buy
13,957
+6
+0% +$509 0.01% 1400
2022
Q3
$1.05M Sell
13,951
-40,958
-75% -$3.09M 0.01% 1439
2022
Q2
$4.46M Buy
54,909
+40,101
+271% +$3.25M 0.02% 631
2022
Q1
$1.3M Sell
14,808
-41,516
-74% -$3.64M 0.01% 1399
2021
Q4
$5.09M Buy
56,324
+38,597
+218% +$3.49M 0.02% 634
2021
Q3
$1.48M Buy
17,727
+888
+5% +$74.3K 0.01% 1252
2021
Q2
$1.4M Buy
16,839
+39
+0.2% +$3.24K 0.01% 1313
2021
Q1
$1.3M Buy
16,800
+248
+1% +$19.1K 0.01% 1264
2020
Q4
$1.27M Buy
16,552
+2,492
+18% +$190K 0.01% 1167
2020
Q3
$1.01M Sell
14,060
-2,914
-17% -$209K 0.01% 1185
2020
Q2
$1.17M Sell
16,974
-3,505
-17% -$241K 0.01% 1033
2020
Q1
$1.25M Sell
20,479
-34,961
-63% -$2.13M 0.01% 868
2019
Q4
$3.81M Buy
55,440
+38,163
+221% +$2.62M 0.03% 562
2019
Q3
$1.06M Sell
17,277
-1,490
-8% -$91K 0.01% 1040
2019
Q2
$1.16M Sell
18,767
-35,397
-65% -$2.18M 0.01% 954
2019
Q1
$3.31M Buy
54,164
+35,929
+197% +$2.19M 0.03% 521
2018
Q4
$1.03M Buy
18,235
+2,983
+20% +$169K 0.01% 919
2018
Q3
$961K Buy
15,252
+1,531
+11% +$96.5K 0.01% 1045
2018
Q2
$774K Sell
13,721
-17,911
-57% -$1.01M 0.01% 1131
2018
Q1
$1.76M Buy
31,632
+2,208
+8% +$123K 0.02% 669
2017
Q4
$1.66M Buy
29,424
+4,272
+17% +$240K 0.02% 652
2017
Q3
$1.41M Buy
25,152
+258
+1% +$14.5K 0.02% 672
2017
Q2
$1.36M Buy
24,894
+376
+2% +$20.6K 0.02% 662
2017
Q1
$1.26M Buy
24,518
+900
+4% +$46.3K 0.02% 629
2016
Q4
$1.12M Buy
23,618
+1,930
+9% +$91.5K 0.02% 619
2016
Q3
$1.09M Buy
21,688
+122
+0.6% +$6.14K 0.02% 642
2016
Q2
$1.09M Sell
21,566
-344
-2% -$17.4K 0.02% 569
2016
Q1
$1.06M Sell
21,910
-2,230
-9% -$107K 0.02% 549
2015
Q4
$1.24M Buy
24,140
+1,840
+8% +$94.4K 0.03% 490
2015
Q3
$1.1M Sell
22,300
-3,556
-14% -$175K 0.03% 454
2015
Q2
$1.41M Buy
25,856
+3,778
+17% +$205K 0.04% 403
2015
Q1
$1.19M Buy
22,078
+2,250
+11% +$121K 0.03% 448
2014
Q4
$987K Buy
19,828
+306
+2% +$15.2K 0.03% 486
2014
Q3
$954K Buy
19,522
+5,246
+37% +$256K 0.03% 543
2014
Q2
$673K Sell
14,276
-558
-4% -$26.3K 0.02% 603
2014
Q1
$675K Buy
14,834
+1,276
+9% +$58.1K 0.03% 572
2013
Q4
$584K Buy
13,558
+2,106
+18% +$90.7K 0.02% 592
2013
Q3
$455K Sell
11,452
-152
-1% -$6.04K 0.02% 667
2013
Q2
$431K Buy
+11,604
New +$431K 0.02% 605